Researcher advances novel therapeutic agent for hemorrhagic stroke

by Tyrel Linkhorn,University of ToledoCofilin signaling, including upstream and downstream pathways affected by secondary injury after ICH. Molecular changes impact motor and post-stroke cogniti

Updated on: May 26,2024

Researcher advances novel therapeutic agent for hemorrhagic stroke

by Tyrel Linkhorn,University of ToledoCofilin signaling, including upstream and downstream pathways affected by secondary injury after ICH. Molecular changes impact motor and post-stroke cogniti

Updated on:May 26,2024

Protein movement reveals brain tumor's weak spot

by Annika Lund,Karolinska InstitutetCredit: Unsplash/CC0 Public DomainProteins do not have a single shape, but are more like dynamic robots. But—how do they actually move? And what does this tel

Updated on: December 20,2023

Protein movement reveals brain tumor's weak spot

by Annika Lund,Karolinska InstitutetCredit: Unsplash/CC0 Public DomainProteins do not have a single shape, but are more like dynamic robots. But—how do they actually move? And what does this tel

Updated on:December 20,2023

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can

Updated on: December 22,2023

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can

Updated on:December 22,2023

New algorithm detects even the smallest cancer metastases across the entire mouse body

byHelmholtz Association of German Research CentresDeepMACT makes use of artificial intelligence to find even the smallest metastases in the entire mouse body. The picture shows single disseminat

Updated on: December 23,2023

New algorithm detects even the smallest cancer metastases across the entire mouse body

byHelmholtz Association of German Research CentresDeepMACT makes use of artificial intelligence to find even the smallest metastases in the entire mouse body. The picture shows single disseminat

Updated on:December 23,2023

Ketamine therapy for mental health a 'Wild west' for doctors and patients

by Dawn Megli, KFF Health NewsOne 10 ml vial of 1000 mg ketamine. Credit: Psychonaught/WikipediaIn late 2022, Sarah Gutilla's treatment-resistant depression had grown so severe, she was actively c

Updated on: April 24,2024

Ketamine therapy for mental health a 'Wild west' for doctors and patients

by Dawn Megli, KFF Health NewsOne 10 ml vial of 1000 mg ketamine. Credit: Psychonaught/WikipediaIn late 2022, Sarah Gutilla's treatment-resistant depression had grown so severe, she was actively c

Updated on:April 24,2024

A machine learning tool can help with diagnosing, monitoring colorectal cancer

Updated on: June 18,2025

A machine learning tool can help with diagnosing, monitoring colorectal cancer

Updated on:June 18,2025

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

Updated on: April 29,2025

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

Updated on:April 29,2025

Endoscopic approaches feasible in surgery for sinonasal cancer

(HealthDay)—Endoscopic approaches are feasible for the surgical resection of sinonasal cancer, according to a study published online Dec. 24 inHead & Neck.Ahmed S. Abdelmeguid, M.D., Ph.D.,

Updated on: December 20,2023

Endoscopic approaches feasible in surgery for sinonasal cancer

(HealthDay)—Endoscopic approaches are feasible for the surgical resection of sinonasal cancer, according to a study published online Dec. 24 inHead & Neck.Ahmed S. Abdelmeguid, M.D., Ph.D.,

Updated on:December 20,2023

Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

byUniversity of Texas M. D. Anderson Cancer CenterCancer cell during cell division. Credit: National Institutes of HealthA study at The University of Texas MD Anderson Cancer Center demonstrated

Updated on: December 22,2023

Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

byUniversity of Texas M. D. Anderson Cancer CenterCancer cell during cell division. Credit: National Institutes of HealthA study at The University of Texas MD Anderson Cancer Center demonstrated

Updated on:December 22,2023

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on: December 26,2023

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on:December 26,2023

Clarifying a synergistic effect between different types of antibodies in cancer treatment

by Kindai UniversityA study by researchers from Japan has revealed that the simultaneous administration of two antibodies with different isotypes targeting a specific membrane protein produced a syner

Updated on: July 17,2024

Clarifying a synergistic effect between different types of antibodies in cancer treatment

by Kindai UniversityA study by researchers from Japan has revealed that the simultaneous administration of two antibodies with different isotypes targeting a specific membrane protein produced a syner

Updated on:July 17,2024

Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

byThe University of Hong KongInactivation of a DNA repair gene called FANCM enhances the formation of DNA damage and chromosomal instability induced by a PARP inhibitor, leading to massive cance

Updated on: August 27,2024

Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

byThe University of Hong KongInactivation of a DNA repair gene called FANCM enhances the formation of DNA damage and chromosomal instability induced by a PARP inhibitor, leading to massive cance

Updated on:August 27,2024